...
【24h】

Over‐the‐Counter Tinnitus “Cures”: Marketers’ Promises Do Not Ring True

机译:在柜台上的耳鸣“治愈”:营销人员的承诺不会响起

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives The Clinical Practice Guideline of the American Academy of Otolaryngology–Head & Neck Surgery (2014) stated that clinicians should not recommend dietary supplements for the treatment of tinnitus. The aim of this study is to characterize over‐the‐counter tinnitus remedies (OTCTR) on the U.S. market, describe the ingredients and prices, and characterize the methods of promoting these products. Methods OTCTR were identified via Web search and visits to retail establishments. Information was collected regarding OTCTR chemical composition, product labeling, advertisements and marketing, price, and customers reviews. Results A wide array of unproven OTCTR exist on today's market. All make unfounded claims of relief from ear ringing. Most of the products considered in this study consist of mixtures of inexpensive and common vitamins, minerals, and/or herbs sold at a premium compared to similar preparations not expressly advertised for tinnitus. Certain brands, most notably Arches Tinnitus Formula (Arches Natural Products Inc., Salt Lake City, UT) and Lipo‐Flavonoid (Clarion Brands Inc., Solon, OH), target otolaryngologists by advertising in specialty journals and prominently featuring supposed endorsement by “Ear‐Nose‐and‐Throat Doctors” in their marketing. Conclusion It is important for otolaryngologists who are caring for tinnitus sufferers to be aware that a robust and diverse market exists for unproven OTC tinnitus remedies. It is troubling that heavily advertised brands profess support by otolaryngologists. Responsible specialty organizations in the field should consider opposing such commercially motivated representations. Otolaryngology journals may wish to adopt a policy along the lines of The Journal of the American Medical Association publications to decline advertisements of dietary supplements that make unproven therapeutic claims. Level of Evidence 5 Laryngoscope , 129:1898–1906, 2019
机译:目标耳鼻咽喉 - 放大器的美国学院的临床实践指南;头颈外科杂志(2014)指出,医生不应该建议膳食补充剂用于治疗耳鸣。这项研究的目的是为了在美国市场上的表征过度的柜台耳鸣救济(OTCTR),描述的成分和价格,表征促进这些产品的方法。方法OTCTR是通过Web搜索和访问的零售店标识。信息是关于OTCTR化学成分,产品标签,广告和营销,价格,客户评论收集。结果一个广泛的未经证实的OTCTR今天的市场上存在。所有使从耳鸣救济的无理要求。大多数在这项研究中考虑的产品组成廉价和普通的维生素,矿物质,和/或与不明确标榜为耳鸣类似品溢价出售草药的混合物。某些品牌,通过广告在专业期刊上最显着的拱门耳鸣式(拱门天然产品公司,盐湖城,UT)和脂类的类黄酮(歌乐品牌公司,索伦,OH),目标耳鼻喉科和突出设有一个被认为代言“耳鼻和咽喉医生”,在他们的营销。结论耳鸣患者必须认识到,一个强大的和多样化的市场存在着未经证实的OTC耳鸣补救它是耳鼻喉科谁是关心很重要的。这是困扰由耳鼻喉科该广告大肆品牌信奉的支持。负责任的专业组织在这一领域应该考虑反对这样的商业动机表示。耳鼻咽喉科杂志不妨通过政策一起,使未经证实的治疗索赔的美国医学协会刊物膳食补充剂的下降广告的线条。证据5喉镜的水平,129:1898-1906,2019

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号